Novomer
Company Details
Status: Private
Employees: 11-50
Location:
Boston, Massachusetts, United States
Type:
sample
Technology:
About: Novomer, Inc. is a leading developer of chemical conversion technology to address market needs for transformable, functional, and high carbon utility materials. Novomer's current focus is in the development of beta-propiolactones and derivatives, using its proprietary Novo22™ catalyst. Our patented technology focuses on catalyst, process conversion, and polymerization techniques to provide chemical intermediates, compostable polymers, and high-performance functionalized lactones. Novomer's investment base includes strategic investors Saudi Aramco, SABIC and DSM and financial investors Flagship Ventures, OVP Ventures, and Physic Ventures. For more information, visit www.novomer.com.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Novomer | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.